Sir Ganga Ram gets 104 yrs old Octogenarian for COVID Vaccination

New Delhi: Mr Tulsi Das Chawla born on 01st November 1917   was  successfully vaccinated with first dose of  CoviShield vaccine yesterday at Sir Ganga Ram Hospital without facing any problem or adverse effects. He exudes zest for life which inspires those who have lost hope after ageing.

Mr Chawla resident of Patel Nagar, New Delhi was in Indian Foreign Service from where he retired in 1975 and was posted in various countries like United States of America , Netherlands,  Pakistan and  Africa.

At the age of 104 Mr Chawla leads an active life and does not suffer from any major Comorbidities. He has 2 sons , 2 daughters,  5 grandchildren and 1 great grand children.

According to Mr Chawla , ” I urge everyone  who is eligible  to come forward to take Covid Vaccine . It is totally safe .”

According to Dr D S Rana , Chairman (BOM) , SGRH ” We are witnessing huge enthusiasm among more than 60 years of age group. Mr Chawla is an inspiration to all of us to come forward with out any hesitation for Covid vaccination.”

Today 476 people were vaccinated at Sgrh .

Related Posts

Lupin Ramps Up Strategy to Counter U.S. Tariff Threat, Posts 52% Profit Surge

Mumbai, August 7, 2025 — Indian pharmaceutical giant Lupin is drawing up a multi-pronged strategy to navigate the looming threat of U.S. tariffs, while celebrating a robust 52% year-on-year surge…

WHO Advises Against Antibiotics for COVID-19 Without Bacterial Infection

Geneva, August 7, 2025 — The World Health Organization (WHO) has issued strong updated clinical recommendations: do not prescribe antibiotics to COVID-19 patients — whether severe or mild — unless…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Piyush Goyal meets pharma industry leaders to discuss R&D, competitiveness boost

Piyush Goyal meets pharma industry leaders to discuss R&D, competitiveness boost

Senores Pharma to Buy Two Teva ANDAs

Senores Pharma to Buy Two Teva ANDAs

Lab-grown rabies antibodies show promise as cheaper, safer alternative

Lab-grown rabies antibodies show promise as cheaper, safer alternative

Lilly launches Mounjaro KwikPen in India

Lilly launches Mounjaro KwikPen in India